Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Chubak

Showing results (121-130 of 182) with videos related to

Pageof 19
Sort By:
JAMA Network Open|December 19, 2024
Optimal Stopping Ages for Colorectal Cancer ScreeningMatthias Harlass, Ronit R Dalmat, Jessica Chubak, et al.
American Journal of Preventive Medicine|April 7, 2016
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare SystemsAndrea N Burnett-Hartman, Shivan J Mehta, Yingye Zheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2026
Longitudinal adherence with stool-based testing for colorectal cancer screening in four US health systemsEthan A Halm, Rasmi Nair, Celette Sugg Skinner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2026
Positive predictive value of symptoms for early-onset colorectal cancerJessica Chubak, Laura Ichikawa, Rebecca A Ziebell, et al.
Journal of General Internal Medicine|May 30, 2025
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management GuidelinesCheryl R Clark, Jacquelyn M Lykken, Patricia M Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal womenShelley S Tworoger, Jessica Chubak, Erin J Aiello, et al.
BMC Cancer|March 29, 2019
Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort studyErin J A Bowles, Onchee Yu, Rebecca Ziebell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2022
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years OldRonit R Dalmat, Rebecca A Ziebell, Aruna Kamineni, et al.
Journal of General Internal Medicine|October 7, 2025
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US ConsortiumEthan A Halm, Natalie J Del Vecchio, Katharine A Rendle, et al.
Psycho-Oncology|February 1, 2019
Use of antidepressants after colon cancer diagnosis and risk of recurrenceGaia Pocobelli, Onchee Yu, Rebecca A Ziebell, et al.
Pageof 19

Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
JAMA Network Open|December 19, 2024
Optimal Stopping Ages for Colorectal Cancer ScreeningMatthias Harlass, Ronit R Dalmat, Jessica Chubak, et al.
American Journal of Preventive Medicine|April 7, 2016
Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare SystemsAndrea N Burnett-Hartman, Shivan J Mehta, Yingye Zheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2026
Longitudinal adherence with stool-based testing for colorectal cancer screening in four US health systemsEthan A Halm, Rasmi Nair, Celette Sugg Skinner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2026
Positive predictive value of symptoms for early-onset colorectal cancerJessica Chubak, Laura Ichikawa, Rebecca A Ziebell, et al.
Journal of General Internal Medicine|May 30, 2025
Barriers to the Equitable Implementation of Risk-Based Cervical Cancer Management GuidelinesCheryl R Clark, Jacquelyn M Lykken, Patricia M Chen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2004
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal womenShelley S Tworoger, Jessica Chubak, Erin J Aiello, et al.
BMC Cancer|March 29, 2019
Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort studyErin J A Bowles, Onchee Yu, Rebecca Ziebell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2022
Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years OldRonit R Dalmat, Rebecca A Ziebell, Aruna Kamineni, et al.
Journal of General Internal Medicine|October 7, 2025
Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US ConsortiumEthan A Halm, Natalie J Del Vecchio, Katharine A Rendle, et al.
Psycho-Oncology|February 1, 2019
Use of antidepressants after colon cancer diagnosis and risk of recurrenceGaia Pocobelli, Onchee Yu, Rebecca A Ziebell, et al.
Pageof 19